Prathyusha Duraibabu Sangamo Therapeutics, Inc (SGMO) insider trading activity

Prathyusha Duraibabu is PRINCIPAL FINANCIAL OFFICER of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 696,718 shares of SGMO, which is worth approximately $306,555. The most recent transaction as insider was on Feb 25, 2023, when has been sold 7,030 shares (Common Stock) at a price of $2.66 per share, resulting in proceeds of $18,699. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 697K

6.42% 3M change

15.47% 12M change

Total Value Held $306,555

Prathyusha Duraibabu Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 25 2023	SELL Payment of exercise price or tax liability	$18,699 $2.66 p/Share	7,030 Reduced 4.99%	133,725 Common Stock
Feb 24 2023	BUY Grant, award, or other acquisition	-	53,438 Added 27.52%	140,755 Common Stock
Jun 11 2022	SELL Payment of exercise price or tax liability	$3,166 $3.76 p/Share	842 Reduced 0.96%	86,617 Common Stock
Apr 25 2022	SELL Payment of exercise price or tax liability	$3,197 $4.83 p/Share	662 Reduced 0.76%	86,772 Common Stock
Mar 25 2022	SELL Payment of exercise price or tax liability	$1,984 $5.75 p/Share	345 Reduced 0.39%	87,434 Common Stock
Feb 25 2022	SELL Payment of exercise price or tax liability	$20,497 $5.9 p/Share	3,474 Reduced 6.91%	46,779 Common Stock
Feb 25 2022	BUY Grant, award, or other acquisition	-	41,000 Added 31.84%	87,779 Common Stock

Jun 11 2021	BUY Grant, award, or other acquisition	-	7,500 Added 13.08%	49,827 Common Stock
Apr 25 2021	SELL Payment of exercise price or tax liability	$7,752 $11.71 p/Share	662 Reduced 1.62%	40,128 Common Stock
Mar 25 2021	SELL Payment of exercise price or tax liability	$4,233 $12.27 p/Share	345 Reduced 0.84%	40,790 Common Stock
Feb 25 2021	SELL Payment of exercise price or tax liability	$20,847 $11.19 p/Share	1,863 Reduced 6.37%	27,385 Common Stock
Feb 25 2021	BUY Grant, award, or other acquisition	-	13,750 Added 25.05%	41,135 Common Stock

Also insider at

ORGO

Organogenesis Holdings Inc. Healthcare

Director